Ashley Stuckwisch
Overview
Explore the profile of Ashley Stuckwisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCluskey S, Muyindike W, Nanfuka V, Omoding D, Komukama N, Barigye I, et al.
J Infect Dis
. 2024 May;
230(3):e622-e630.
PMID: 38748986
Background: Tenofovir/lamivudine/dolutegravir (TLD) is the preferred first-line antiretroviral therapy (ART) regimen for people with HIV (PWH), including those who were previously virologically suppressed on nonnucleoside reverse transcriptase inhibitors (NNRTIs). We...
2.
Bassett I, Yan J, Giddy J, Ross D, Bogart L, Stuckwisch A, et al.
AIDS Care
. 2023 Mar;
35(12):2016-2023.
PMID: 36942651
Characterizing spatial distribution of HIV outcomes is vital for targeting interventions to areas most at risk. We performed spatial analysis to identify geographic clusters and factors associated with mortality in...
3.
Aiken T, Erbe A, Zebertavage L, Komjathy D, Feils A, Rodriguez M, et al.
J Immunother Cancer
. 2022 May;
10(5).
PMID: 35618290
Background: Most pediatric cancers are considered immunologically cold with relatively few responding to immune checkpoint inhibition. We recently described an effective combination radio-immunotherapy treatment regimen ( ombination daptive- nnate immunotherapy...
4.
Bassett I, Yan J, Govere S, Khumalo A, Ngobese N, Shazi Z, et al.
J Int AIDS Soc
. 2022 Jan;
25(1):e25877.
PMID: 35077611
Introduction: South Africa's government-led Central Chronic Medication Dispensing and Distribution (CCMDD) program offers people living with HIV the option to collect antiretroviral therapy at their choice of community- or clinic-based...
5.
Aiken T, Komjathy D, Rodriguez M, Stuckwisch A, Feils A, Subbotin V, et al.
J Immunother Cancer
. 2022 Jan;
10(1).
PMID: 35039460
Background: Surgical resection remains an important component of multimodality treatment for most solid tumors. Neoadjuvant immunotherapy has several potential advantages, including in-situ tumor vaccination and pathologic assessment of response in...
6.
Wara N, Psaros C, Govere S, Dladla N, Stuckwisch A, Zionts D, et al.
Reprod Health
. 2021 Aug;
18(1):178.
PMID: 34461925
Background: South Africa faces a high burden of unmet contraceptive need, particularly among adolescent girls and young women. Providing contraception in community-based venues may overcome barriers to contraceptive access. Our...
7.
Voeller J, Erbe A, Slowinski J, Rasmussen K, Carlson P, Hoefges A, et al.
J Immunother Cancer
. 2019 Dec;
7(1):344.
PMID: 31810498
Background: Unlike some adult cancers, most pediatric cancers are considered immunologically cold and generally less responsive to immunotherapy. While immunotherapy has already been incorporated into standard of care treatment for...